Latest news
ClonOrgan raises 200M yuan to advance xenotransplant trials - DealroomDealroom · Sat, 08 Aug 2026 02:06:53 GMTGlasgow-based Mironid raises €39.9 million in Series B to advance rare kidney disease treatment - EU-StartupsEU-Startups · Fri, 07 Aug 2026 12:14:34 GMTCAR T-Cell Therapy, Biomarkers, Clinical Trials, and Bladder Cancer Advances - The American Journal of Managed CareThe American Journal of Managed Care · Thu, 06 Aug 2026 21:34:04 GMTNuwellis Appoints Dale Brady As Principal R&D Engineer To Advance Medical Device Development - Pulse 2.0Pulse 2.0 · Thu, 06 Aug 2026 19:06:25 GMTClarivate Scales Agentic AI Across Cortellis to Advance Drug Development - Yahoo FinanceYahoo Finance · Thu, 06 Aug 2026 08:00:00 GMTH1 and Novo Nordisk Partner to Advance AI-Driven Clinical Development - HLTHHLTH · Wed, 05 Aug 2026 11:16:20 GMTArcheus Technologies Reconstitutes Advisory Board to Advance Clinical-Stage Radiopharmaceutical Pipeline - BioSpaceBioSpace · Wed, 05 Aug 2026 08:21:13 GMTMironid raises $46 million in Series B financing to advance clinical development of its treatment for rare kidney disease - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 06:13:34 GMT